| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |